Tailoring Maintenance Therapy by Patient Risk: Lenalidomide Alone vs Combination Approaches

Q&A: Transitioning Myeloma Care to the Community Level

Formal communication could help ease the transition of care from specialized myeloma centers to community clinic, according to Diane Moran, RN, MA, EdM.

Tailoring Maintenance Therapy by Patient Risk: Lenalidomide Alone vs Combination Approaches

Panelists discuss how maintenance therapy should be tailored based on risk profiles, with standard-risk patients receiving single-agent lenalidomide while high-risk patients may benefit from combination maintenance strategies to achieve more durable responses.